However, silencing FAM46A via FAM46A -shRNA enhance the cytotoxic effect of CDDP on ovarian cancer cells, which resulted in remission tumor progression and increased active caspase 3 cells compared with that in the control group (Figure 4(c)). The gene discussed is CASP3; the disease is neoplasm.